Shire Biochem Inc.
Records under this name other than patents Shire Biochem Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,595,057 | Streptococcus Pyogenes Antigens and Corresponding DNA Fragments Formerly held Term ended Term ended Dec 5, 2025 · High confidence | Term ended | Term ended Dec 5, 2025 | High confidence |
| US 7,955,835 | Stereoselective Process for the Production of Dioxolane Nucleoside Analogues Formerly held Term ended Term ended Jun 13, 2025 · High confidence | Term ended | Term ended Jun 13, 2025 | High confidence |
| US 7,914,794 | Novel Group B Streptococcus Antigens Formerly held Term ended Term ended Jan 3, 2025 · Medium confidence | Term ended | Term ended Jan 3, 2025 | Medium confidence |
| US 7,465,465 | Pharmaceutical Formulation Comprising Lanthanum Compounds Formerly held Term ended Term ended Oct 9, 2024 · High confidence | Term ended | Term ended Oct 9, 2024 | High confidence |
| US RE39,155 | Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B Term ended Term ended Jul 4, 2023 · USPTO record | Term ended | Term ended Jul 4, 2023 | USPTO record |
| US 7,393,536 | Group B Streptococcus Antigens and Corresponding DNA Fragments Formerly held Term ended Term ended May 22, 2023 · High confidence | Term ended | Term ended May 22, 2023 | High confidence |
| US 7,335,368 | BVH-A2 and BVH-A3 Antigens of Group B Streptococcus Formerly held Term ended Term ended May 3, 2023 · High confidence | Term ended | Term ended May 3, 2023 | High confidence |
| US 7,442,813 | Process for Producing Dioxolane Nucleoside Analogues Held by another company Term ended Term ended Jan 23, 2023 · High confidence | Term ended | Term ended Jan 23, 2023 | High confidence |
| US 6,645,972 | Methods of Treating Leukemia Formerly held Term ended Term ended Nov 4, 2022 · High confidence | Term ended | Term ended Nov 4, 2022 | High confidence |
| US 6,800,639 | Pharmaceutical Combination for the Treatment of Cancer Formerly held Term ended Term ended Mar 25, 2022 · High confidence | Term ended | Term ended Mar 25, 2022 | High confidence |